<p><i><strong>Secured multi-regional patent assets, strengthening Ainos' AI Nose technology.</strong></i></p><p><i><strong>Expanded VELDONA&reg; patent portfolio with a new invention patent for treatments and preventions for coronavirus infections.</strong></i></p><p><i><strong>Progressed clinical trials for VELDONA&reg;, including new studies on Sj&ouml;gren's syndrome and HIV-related oral warts.</strong></i></p>

<p><i><strong>Strengthens AI Nose Gas Sensing Technology with Additional Exclusively Licensed Patents</strong></i></p><p><i><strong>Secures Exclusive Rights to Breakthrough Nitrogen-Oxygen Separation Technology with Superior Energy Efficiency and Ultra-Low Carbon Emissions, Advancing Sustainable Medical Practices</strong></i></p>